[SGMO] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
01-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -5.97%
YoY- -36.02%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 25,800 54,851 26,837 13,077 8,922 9,121 14,952 9.50%
PBT -40,567 4,501 -19,219 -13,091 -9,611 -15,648 -4,319 45.20%
Tax 108 179 -1,246 -468 13 -1,635 -199 -
NP -40,604 4,555 -18,664 -13,091 -9,624 -14,013 -4,319 45.22%
Tax Rate - -3.98% - - - - - -
Total Cost 66,404 50,296 45,501 26,168 18,546 23,134 19,271 22.87%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -157.38 8.30 -69.55 -100.11 -107.87 -153.63 -28.89 32.61%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.29 0.04 -0.18 -0.15 -0.14 -0.20 -0.06 29.99%
EPS Diluted -0.29 0.04 -0.18 -0.15 -0.14 -0.20 -0.06 29.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.